Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
YESINTEK is approved for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries
Cancer cases in India estimated to reach 1.57 million in 2025
Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
Biocon’s subsidiary Biocon Biologics Limited, which also participated independently in the assessment for the first time, reported an S&P Global ESG Score of 53
The camp, operational daily from 12 PM to 4 PM, offers free health check-ups, blood pressure monitoring
Services like 24/7 Ayush Multi-OPD clinics, mobile healthcare units, free distribution of Ayush medicines, and yoga camps are there for all visitors
Subscribe To Our Newsletter & Stay Updated
